http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011153105-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cd3ea6c52ef8544c67c051a2ef489b3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 2010-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_323ce54d19671197a821d412b6e35477 |
| publicationDate | 2011-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2011153105-A |
| titleOfInvention | 2-anilino-4-phenylthiazole compound having erythropoietin production promoting action |
| abstract | The present invention provides a low molecular weight compound having EPO production promoting action. The present invention relates to the following general formula (1): [Where: R 1 represents a hydrogen atom, a C 1-6 alkyl group, a carboxyl group or an amino group, R 2 represents a hydrogen atom or a halogen atom] It is related with the EPO production promoter which uses 2-anilino-4-phenylthiazole compound represented by these, its salt, or those solvates as an active ingredient. Specifically, the present invention relates to a preventive and / or therapeutic agent for diseases caused by reduced EPO production, such as anemia. [Selection figure] None |
| priorityDate | 2010-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 150.